Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Sep 10, 2019- New research found Abbott's algorithm created through machine learning could give doctors a more individualized calculation, leveraging factors such as age, sex and the changing dynamics of troponin protein levels in the blood, to improve heart attack diagnosis- This technology is the first machine learning developed algorithm that combines high sensitive troponin testing with other patient details to help doctors better determine if a heart attack is occurring- Sep 9, 2019- New initiative will provide vital primary care services within a 30-minute walk of all Rwandans' homes- Health post workers will test and treat pregnant women for multiple infectious diseases that can have serious health consequences for both mothers and newborns if not diagnosed and treated early
Sep 6, 2019- Beckham will serve as spokesperson and creative director for Pedialyte- Pedialyte provides advanced rehydration, with an optimal balance of electrolytes and glucose- Sep 5, 2019- TRILUMINATE Pivotal trial is the world's first randomized clinical trial to evaluate transcatheter tricuspid valve repair in patients with severe tricuspid regurgitation- There are currently no approved transcatheter tricuspid repair treatments, limiting options for patients with leaky tricuspid valves who are at high risk for surgery- Abbott's TriClip tricuspid valve repair system is built on the company's proven MitraClip technology
- Aug 26, 2019- The TRACK-TBI study found that 64% of people with the highest levels of a protein in the blood were confirmed to have brain injury through an MRI scan, even when a CT scan did not detect it- Abbott's diagnostic test, currently in development, is poised to be the first point-of-care blood test for assessing concussions on its next generation i-STAT™ device, providing doctors results in 15 minutes